Get started
Author

Ashish Shivram Ramteke

Observed names: ASHISH S. RAMTEKE, Ashish S Ramteke, Ashish S. Ramteke
ORCID: 0000-0003-4127-3235
Observed ORCID: 0000-0003-4127-3235
OpenAlex ID: A5082588069
Dual immune checkpoints inhibition: Cancer treatment and immunological modes of action
2023 · Ashish S. Ramteke · Journal of Drug Delivery and Therapeutics · 2
PDF
Combination of CTLA-4 and PD-1/PD-L1 Immune Checkpoints Inhibitors for Treatment of Cancer
2023 · Ashish S. Ramteke · International Journal of Pharmaceutical Sciences Review and Research · 1
PDF
Human Immunodeficiency Virus: Elusive Perspectives and Novel Vaccination Approaches
2025 · ASHISH S. RAMTEKE · International Journal of Pharmacy and Pharmaceutical Sciences
PDF
Mechanism, potency and restriction of anti-CTLA-4 and anti-PD-1 immunotherapies in cancer
2024 · Ashish Shivram Ramteke · International Journal of Pharmacy and Pharmaceutical Science
PDF
Nanovaccine approach to prevent binding of SARS-CoV-2 surface glycoprotein with ACE2 and TMPRSS2 receptor
2024 · Ashish Shivram Ramteke · International Journal of Pharmaceutical and Clinical Research
PDF
Efficiency and Future Significance of CTLA-4 and PD-1 Checkpoints Blockade Immunotherapy
2023 · Ashish Shivram Ramteke · International Journal of Pharmaceutical Sciences Review and Research
PDF
Lipid Nanobiotechnology: An Alternative Strategy to Targeted Drug and Vaccine Delivery System and Its Biomedical Applications as Nanomedicine
2023 · Ashish S Ramteke · International Journal of Medical & Pharmaceutical Sciences
PDF
Trichoderma Species: Isolation, Characterization, Cultivation and Their Role as Effective Biopesticides
2019 · Ashish Shivram Ramteke
Works count: 10
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type